![](https://pharmaphorum.com/sites/default/files/2024-07/AbbVie_Roopal_Thakkar_Thomas_Hudson.jpg)
AbbVie lines up Thakkar to replace outgoing CSO Hudson
There is change at the top of AbbVie’s R&D organisation, as chief scientific officer Thomas Hudson announces his retirement after four years in the role. He will be replaced as head of AbbVie’s global R&D organisation by Roopal Thakkar, who is …